Search Results - Dirk Sibbing

Refine Results
  1. 1
    Pre-treatment with P2Y<sub>12</sub>inhibitors in ACS patients: who, when, why, and which agent?

    Pre-treatment with P2Y<sub>12</sub>inhibitors in ACS patients: who, when, why, and which agent? by Dirk Sibbing, Adnan Kastrati, Peter B. Berger

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    P2Y <sub>12</sub> -ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes

    P2Y <sub>12</sub> -ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes by Laurent Bonello, Dominick J. Angiolillo, Dániel Aradi, Dirk Sibbing

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients

    Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients by Dirk Sibbing, Steven R. Steinhubl, S. Schulz, Albert Schömig, Adnan Kastrati

    Published 2010
    Get full text
    Carta
    Save to List
    Saved in:
  4. 4
    Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation

    Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation by Nikolaus Sarafoff, Amadea M. Martischnig, Jill Wealer, Katharina Mayer, Julinda Mehilli, Dirk Sibbing, Adnan Kastrati

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days

    A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days by Nicolas von Beckerath, Adnan Kastrati, Anna Wieczorek, Gisela Pogátsa-Murray, Dirk Sibbing, Isolde Graf, Albert Schömig

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment

    Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment by Siegmund Braun, Stefan Jawansky, Wolfgang Vogt, Julinda Mehilli, Albert Schömig, Adnan Kastrati, Nicolas von Beckerath, Dirk Sibbing

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement

    Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement by Dirk Sibbing, S. Schulz, S. Braun, Tanja Morath, Julia Stegherr, Julinda Mehilli, Albert Schömig, Nicolas von Beckerath, Adnan Kastrati

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis

    Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis by Dirk Sibbing, Siegmund Braun, Tanja Morath, Julinda Mehilli, Wolfgang Vogt, Albert Schömig, Adnan Kastrati, Nicolas von Beckerath

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting

    No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting by Dirk Sibbing, W. Koch, Steffen Maßberg, Robert A. Byrne, Julinda Mehilli, S. Schulz, Kerstin Mayer, Isabell Bernlochner, Albert Schömig, A. Kastrati

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement

    Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement by Dirk Sibbing, Werner Koch, Daniela Gebhard, Tibor Schuster, Siegmund Braun, Julia Stegherr, Tanja Morath, Albert Schömig, Nicolas von Beckerath, Adnan Kastrati

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

    Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention by Dirk Sibbing, Julia Stegherr, Wolfgang Latz, Werner Koch, Julinda Mehilli, K. Dörrler, Tanja Morath, Albert Schömig, Adnan Kastrati, N. von Beckerath

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy

    Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy by Dirk Sibbing, Doris Gebhard, Werner Koch, S. Braun, Julia Stegherr, Tanja Morath, N. von Beckerath, Julinda Mehilli, Albert Schömig, Tibor Schuster, Adnan Kastrati

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidel... by Emanuele Barbato, Julinda Mehilli, Dirk Sibbing, George C.M. Siontis, Jean‐Philippe Collet, Hölger Thiele, Adnan Kastrati, Mamas A. Mamas, Stephan Windecker

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Reply

    Reply by Katharina Mayer, Isabell Bernlochner, Siegmund Braun, S. Schulz, Martin Orban, Tanja Morath, Lisena Cala, Petra Hoppmann, Heribert Schunkert, Karl‐Ludwig Laugwitz, Adnan Kastrati, Dirk Sibbing

    Published 2015
    Get full text
    Carta
    Save to List
    Saved in:
  15. 15
    Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention

    Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention by Dániel Aradi, Robert F. Storey, András Komócsi, Dietmar Trenk, Dietrich C. Gulba, Róbert Gábor Kiss, Steen Husted, Laurent Bonello, Dirk Sibbing, Jean‐Philippe Collet, Kurt Huber

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Randomized Comparison of Intensified and Standard P2Y <sub>12</sub> -Receptor-Inhibition Before Elective Percutaneous Coronary Intervention

    Randomized Comparison of Intensified and Standard P2Y <sub>12</sub> -Receptor-Inhibition Before Elective Percutaneous Coronary Intervention by Julinda Mehilli, Moritz Baquet, Willibald Hochholzer, Katharina Mayer, Christian Tesche, Dániel Aradi, Yujun Xu, Manuela Thienel, Sarah Gschwendtner, Magda Zadrozny, David Jochheim, Dirk Sibbing, Stefanie Schüpke, Ulrich Mansmann, Ellen Hoffmann, Adnan Kastrati, Franz‐Josef Neumann, Steffen Maßberg

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy

    Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC work... by Victor Aboyans, Rupert Bauersachs, Lucia Mazzolai, Marianne Brodmann, José F. Rodríguez‐Palomares, Sebastian Debus, Jean‐Philippe Collet, Heinz Drexel, Christine Espinola‐Klein, Basil S. Lewis, Marco Roffi, Dirk Sibbing, Henrik Sillesen, Eugenio Stabile, Oliver Schlager, Marco De Carlo

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation

    Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation by K. Anette Fiedler, Michael Mæng, Julinda Mehilli, Stefanie Schüpke, Robert A. Byrne, Dirk Sibbing, Petra Hoppmann, Simon Schneider, Massimiliano Fusaro, Ilka Ott, Steen Dalby Kristensen, Tareq Ibrahim, Steffen Maßberg, Heribert Schunkert, Karl‐Ludwig Laugwitz, Adnan Kastrati, Nikolaus Sarafoff

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials

    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials by Mattía Galli, Stefano Benenati, Francesco Franchi, Fabiana Rollini, Davide Capodanno, Giuseppe Biondi‐Zoccai, Giovanni Maria Vescovo, Larisa H. Cavallari, Behnood Bikdeli, Jurriën M. ten Berg, Roxana Mehran, C. Michael Gibson, Filippo Crea, Naveen L. Pereira, Dirk Sibbing, Dominick J. Angiolillo

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society

    Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the E... by Diana A. Gorog, Ying X. Gue, Tze‐Fan Chao, Laurent Fauchier, José Luis Ferreiro, Kurt Huber, Stavros V. Konstantinidis, Deirdre A. Lane, Francisco Marı́n, Jonas Oldgren, Tatjana Potpara, Vanessa Roldán, Andrea Rubboli, Dirk Sibbing, Hung‐Fat Tse, Gemma Vilahur, Gregory Lip

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: